BioWorld MedTech

Jan. 8, 2014

Delphinus gains 501(k) for breast ultrasound tomography

Delphinus (Plymouth Township, Michigan) said it has received FDA 510(k) clearance for its SoftVue whole breast ultrasound tomography system, approved for diagnostic breast imaging. Read More

Sapheon continues in mission to gain FDA approval for VenaSeal

Washington Roundup: CRS analysis says med-tech tax is 'challenging to justify'

Regional Innovation Review: UT a source of innovation in Memphis medical technology

Financings roundup: Omicia closes $6.8M Series A funding round

BioWorld Survey: Let Us Know What You Think!

Deals roundup: Safeguard partner Alverix acquired by BD for $40M

Agreements/contracts: Foundation extends support of Novartis oncology program

HIT roundup: Bosch, Remedy launch new Health Buddy Web

Patent watch: USPTO accepts Tricast's first patent application

People in Places

Product briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...